1. Deubiquitinase USP37 Is Activated by CDK2 to Antagonize APCCDH1 and Promote S Phase Entry
- Author
-
Jennie R. Lill, Gwanghee Lee, Matthew K. Summers, Jinfeng Liu, Guowei Fang, Donald S. Kirkpatrick, XiaoDong Huang, Victoria Pham, Vishva M. Dixit, and Peter K. Jackson
- Subjects
Cyclin A ,Mitosis ,CDC20 ,Article ,Deubiquitinating enzyme ,APC/C activator protein CDH1 ,S Phase ,Antigens, CD ,Endopeptidases ,Humans ,Phosphorylation ,Polyubiquitin ,Molecular Biology ,Cyclin ,biology ,Cyclin-dependent kinase 2 ,Cyclin-Dependent Kinase 2 ,technology, industry, and agriculture ,Cell Biology ,equipment and supplies ,Cadherins ,Ubiquitin ligase ,Cell biology ,E2F Transcription Factors ,Up-Regulation ,HEK293 Cells ,biology.protein ,Cancer research ,hormones, hormone substitutes, and hormone antagonists - Abstract
Summary Cell cycle progression requires the E3 ubiquitin ligase anaphase-promoting complex (APC/C), which uses the substrate adaptors CDC20 and CDH1 to target proteins for proteasomal degradation. The APC CDH1 substrate cyclin A is critical for the G1/S transition and, paradoxically, accumulates even when APC CDH1 is active. We show that the deubiquitinase USP37 binds CDH1 and removes degradative polyubiquitin from cyclin A. USP37 was induced by E2F transcription factors in G1, peaked at G1/S, and was degraded in late mitosis. Phosphorylation of USP37 by CDK2 stimulated its full activity. USP37 overexpression caused premature cyclin A accumulation in G1 and accelerated S phase entry, whereas USP37 knockdown delayed these events. USP37 was inactive in mitosis because it was no longer phosphorylated by CDK2. Indeed, it switched from an antagonist to a substrate of APC CDH1 and was modified with degradative K11-linked polyubiquitin.
- Published
- 2011
- Full Text
- View/download PDF